| Cat. No. |
Size |
Price |
Figures |
RP11322-5 mg
| 5 mg | $ 23.75 | MSDS: 20080714213805 (PDF) STRUCTURE:
 Zoom
References:
- Ma LJ, Nakamura, et al. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J. Am. Soc. Nephrol. Apr 2005; 16(4): 966-976.
- Ostendorf T, et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J. Am. Soc. Nephrol. Apr 2006; 17(4): 1054-1062.
- Moreau ME, et al. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation. J. Pharmacol. Exp. Ther. Dec 2005; 315(3): 1065-1074.
|
|---|
| Full Name | | Angiotensin I-Converting Enzyme Inhibitor (Bradykinin Potentiator B) |
|
| Alias |
Bradykinin Potentiator B, Angiotensin I Converting Enzyme Inhibitor; Angiotensin 1 Converting Enzyme Inhibitor |
Sequence (three-letter code) | pGlu-GLY-LEU-PRO-PRO-ARG-PRO-LYS-ILE-PRO-PRO |
| Solubility | The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. |
|---|
| Formula | C56H91N15O13 |
| M.W. | 1182.4 |
| Cas | 30892-86-5 |
|---|
| Purity | > 95% |
| Storage | Before use, store the peptide in the DRY form at 0°C - 5°C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions. |